Shares of Sourcebio International Plc (LON:SBI – Get Free Report) shot up 4.5% during trading on Thursday . The stock traded as high as GBX 125 ($1.56) and last traded at GBX 115 ($1.43). 1,571,282 shares were traded during mid-day trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.37).
Sourcebio International Price Performance
The stock’s fifty day moving average price is GBX 115 and its 200-day moving average price is GBX 115. The company has a debt-to-equity ratio of 35.10, a quick ratio of 1.78 and a current ratio of 1.91. The firm has a market cap of £85.31 million and a PE ratio of 1,277.78.
About Sourcebio International
Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.
Featured Articles
- Five stocks we like better than Sourcebio International
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Comprehensive PepsiCo Stock Analysis
- High Flyers: 3 Natural Gas Stocks for March 2022
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- The How and Why of Investing in Gold Stocks
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Sourcebio International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sourcebio International and related companies with MarketBeat.com's FREE daily email newsletter.